Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.44M | 7.76M | 6.52M | 5.99M | 3.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.61M | 23.81M | 21.91M | 19.66M | 18.13M |
| Operating Income | -23.61M | -23.81M | -21.91M | -19.66M | -18.13M |
| Income Before Tax | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M |
| EBIT | -23.61M | -23.81M | -21.91M | -19.66M | -18.13M |
| EBITDA | -23.46M | -23.62M | -21.76M | -19.50M | -17.97M |
| EPS Basic | -0.46 | -0.46 | -0.41 | -0.62 | -3.38 |
| Normalized Basic EPS | -0.29 | -0.29 | -0.26 | -0.39 | -2.11 |
| EPS Diluted | -0.46 | -0.46 | -0.41 | -0.62 | -3.38 |
| Normalized Diluted EPS | -0.29 | -0.29 | -0.26 | -0.39 | -2.11 |
| Average Basic Shares Outstanding | 44.64M | 44.26M | 44.12M | 26.60M | 4.69M |
| Average Diluted Shares Outstanding | 44.64M | 44.26M | 44.12M | 26.60M | 4.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |